Yuhei Takado

Yuhei Takado

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Neuron
Verified
Journal Article
Closed access
KTKenji Tagai
Kenji Tagai
MOMaiko Ono
Maiko Ono
MKManabu Kubota
Manabu Kubota
SKSoichiro Kitamura
Soichiro Kitamura
KTKeisuke Takahata
Keisuke Takahata
HSHitoshi Shimada
Hitoshi Shimada

22 October 2021 in Science Advances
Verified
Journal Article
Open access
HSHideaki Sato
Hideaki Sato
YTYuhei Takado
Yuhei Takado
STSakiko Toyoda
Sakiko Toyoda
MTMasako Tsukamoto-Yasui
Masako Tsukamoto-Yasui
KMKeiichiro Minatohara
Keiichiro Minatohara
MHMakoto Higuchi
Makoto Higuchi
Intake of specific seven essential amino acids affects the pathology of the brain.

13 September 2021 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
PDF file
YTYuhei Takado
Yuhei Takado
HTHiroyuki Takuwa
Hiroyuki Takuwa
KSKazuaki Sampei
Kazuaki Sampei
TUTakuya Urushihata
Takuya Urushihata
MTManami Takahashi
Manami Takahashi
MHMakoto Higuchi
Makoto Higuchi
To assess if magnetic resonance spectroscopy (MRS)-measured Glutamate (Glu) and GABA reflect excitatory and inhibitory neural activities, respectively, we conducted MRS measurements along with two-photon mesoscopic imaging of calcium signals in excitatory and inhibitory neurons of living, unanesthetized mice. For monitoring stimulus-driven activations of a brain region, MRS signals and mesoscopic neural activities were measured during two consecutive sessions of 15-min prolonged sensory stimulations. In the first session, putative excitatory neuronal activities were increased, while inhibitory neuronal activities remained at the baseline level. In the second half, while excitatory neuronal activities remained elevated, inhibitory neuronal activities were significantly enhanced. We assessed regional neurochemical statuses by measuring MRS signals, which were overall in accordance with the neural activities, and neuronal activities and neurochemical statuses in a mouse model of Dravet syndrome under resting condition. Mesoscopic assessments showed that activities of inhibitory neurons in the cortex were diminished relative to wild-type mice in contrast to spared activities of excitatory neurons. Consistent with these observations, the Dravet model exhibited lower concentrations of GABA than wild-type controls. Collectively, the current investigations demonstrate that MRS-measured Glu and GABA can reflect spontaneous and stimulated activities of neurons producing and releasing these neurotransmitters in an awake condition.

28 September 2023 in Annals of Neurology
Verified
Journal Article
Open access
KHKosei Hirata
Kosei Hirata
KMKiwamu Matsuoka
Kiwamu Matsuoka
KTKenji Tagai
Kenji Tagai
HEHironobu Endo
Hironobu Endo
HTHarutsugu Tatebe
Harutsugu Tatebe
YTYuhei Takado
Yuhei Takado
Objective: Increasing evidence suggests that reactive astrocytes are associated with Alzheimer's disease (AD). However, its underlying pathogenesis remains unknown. Given the role of astrocytes in energy metabolism, reactive astrocytes may contribute to altered brain energy metabolism. Astrocytes are primarily considered glycolytic cells, suggesting a preference for lactate production. This study aimed to examine alterations in astrocytic activities and their association with brain lactate levels in AD.Methods: The study included 30 AD and 30 cognitively unimpaired participants. For AD participants, amyloid and tau depositions were confirmed by positron emission tomography using [11C]PiB and [18F]florzolotau, respectively. Myo‐inositol, an astroglial marker, and lactate in the posterior cingulate cortex were quantified by magnetic resonance spectroscopy. These magnetic resonance spectroscopy metabolites were compared with plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker, and amyloid and tau positron emission tomography.Results: Myo‐inositol and lactate levels were higher in AD patients than in cognitively unimpaired participants (p < 0.05). Myo‐inositol levels correlated with lactate levels (r = 0.272, p = 0.047). Myo‐inositol and lactate levels were positively associated with the Clinical Dementia Rating sum‐of‐boxes scores (p < 0.05). Significant correlations were noted between myo‐inositol levels and plasma glial fibrillary acidic protein, tau phosphorylated at threonine 181 levels, and amyloid and tau positron emission tomography accumulation in the posterior cingulate cortex (p < 0.05).Interpretation: We found high myo‐inositol levels accompanied by increased lactate levels in the posterior cingulate cortex in AD patients, indicating a link between reactive astrocytes and altered brain energy metabolism. Myo‐inositol and plasma glial fibrillary acidic protein may reflect similar astrocytic changes as biomarkers of AD. ANN NEUROL 2024;95:104–115

28 August 2022 in Movement Disorders
Verified
Journal Article
Open access
HEHironobu Endo
Hironobu Endo
KTKenji Tagai
Kenji Tagai
MOMaiko Ono
Maiko Ono
YIYoko Ikoma
Yoko Ikoma
AOAsaka Oyama
Asaka Oyama
MHMakoto Higuchi
Makoto Higuchi
Background: We recently developed a positron emission tomography (PET) probe, [18F]PM‐PBB3, to detect tau lesions in diverse tauopathies, including mixed three‐repeat and four‐repeat (3R + 4R) tau fibrils in Alzheimer's disease (AD) and 4R tau aggregates in progressive supranuclear palsy (PSP). For wider availability of this technology for clinical settings, bias‐free quantitative evaluation of tau images without a priori disease information is needed.Objective: We aimed to establish tau PET pathology indices to characterize PSP and AD using a machine learning approach and test their validity and tracer capabilities.Methods: Data were obtained from 50 healthy control subjects, 46 patients with PSP Richardson syndrome, and 37 patients on the AD continuum. Tau PET data from 114 regions of interest were subjected to Elastic Net cross‐validation linear classification analysis with a one‐versus‐the‐rest multiclass strategy to obtain a linear function that discriminates diseases by maximizing the area under the receiver operating characteristic curve. We defined PSP‐ and AD‐tau scores for each participant as values of the functions optimized for differentiating PSP (4R) and AD (3R + 4R), respectively, from others.Results: The discriminatory ability of PSP‐ and AD‐tau scores assessed as the area under the receiver operating characteristic curve was 0.98 and 1.00, respectively. PSP‐tau scores correlated with the PSP rating scale in patients with PSP, and AD‐tau scores correlated with Mini‐Mental State Examination scores in healthy control–AD continuum patients. The globus pallidus and amygdala were highlighted as regions with high weight coefficients for determining PSP‐ and AD‐tau scores, respectively.Conclusions: These findings highlight our technology's unbiased capability to identify topologies of 3R + 4R versus 4R tau deposits. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

19 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
YTYuhei Takado
Yuhei Takado
NSNaoto Sato
Naoto Sato
YKYuta Kanbe
Yuta Kanbe
MTMoyoko Tomiyasu
Moyoko Tomiyasu
LXLijing Xin
Lijing Xin
TOTakayuki Obata
Takayuki Obata
Both glutamine (Gln) and glutamate (Glu) are known to exist in plasma and brain. However, despite the assumed relationship between brain and plasma, no studies have clarified the association between them. Proton magnetic resonance spectroscopy (MRS) was sequentially performed twice, with a 60-min interval, on 10 males and 10 females using a 3T scanner. Blood samples for liquid chromatography–mass spectrometry (LC/MS) to measure Gln and Glu concentrations in plasma were collected during the time interval between the two MRS sessions. MRS voxels of interest were localized at the posterior cingulate cortex (PCC) and cerebellum (Cbll) and measured by the SPECIAL sequence. Spearman’s correlation coefficient was used to examine the association between brain and plasma metabolites. The Gln concentrations in PCC (mean of two measurements) were positively correlated with Gln concentrations in plasma (p < 0.01, r = 0.72). However, the Glu concentrations in the two regions were not correlated with those in plasma. Consideration of the different dynamics of Gln and Glu between plasma and brain is crucial when addressing the pathomechanism and therapeutic strategies for brain disorders such as Alzheimer’s disease and hepatic encephalopathy.